SCHEMBL4581510

SCHEMBL4581510

CCN(c1ccc(C#N)c(NCCOC)c1)c1cc(OC)c(OC)c(OC)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.45
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 1/20 0.38
ATM Q13315 2/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SRC P12931 3/20 0.35
AR P10275 2/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
FGFR4 P22455 2/20 0.33
CXCR6 O00574 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4581828 0.79 LMNA (0.38) ALDH1A1KMT2AMEN1KDM4ELMNA
SCHEMBL4581085 0.77 DYRK1A (0.46) DYRK1AALDH1A1KMT2AMEN1ATM
SCHEMBL4581593 0.75 DYRK1A (0.48) DYRK1AALDH1A1KMT2AMEN1ATM
SCHEMBL4581081 0.75 DYRK1A (0.46) DYRK1AALDH1A1KMT2AMEN1ATM
SCHEMBL18034714 0.69 ALDH1A1 (0.49) DYRK1AALDH1A1KDM4ELMNAAR
SCHEMBL12819770 0.69 ALDH1A1 (0.39) DYRK1AALDH1A1KDM4ELMNAHPGD
SCHEMBL4579455 0.68 DYRK1A (0.66) DYRK1ASRCFGFR4
SCHEMBL4580812 0.68 KDM4E (0.42) ALDH1A1KMT2AMEN1ATMKDM4E
SCHEMBL29530279 0.66 KDM4E (0.53) ALDH1A1KMT2AMEN1KDM4ELMNA
SCHEMBL7522660 0.66 KDM4E (0.53) ALDH1A1KMT2AMEN1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076800-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-03-27 US claimed
US-20080076800-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-03-27 US disclosed
US-20080076800-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-03-27 US disclosed
US-20080076800-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076800-A1 Benzene, Pyridine, and Pyridazine Derivatives RB1, MKI67, CCNB1 DYRK1A 2145/4885ALDH1A1 767/4885KMT2A 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.